Yarbrough Capital LLC Has $273,000 Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)
Yarbrough Capital LLC Has $273,000 Holdings in Cellebrite DI Ltd. (NASDAQ:CLBT)
Yarbrough Capital LLC decreased its position in Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating) by 17.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 53,492 shares of the company's stock after selling 11,144 shares during the quarter. Yarbrough Capital LLC's holdings in Cellebrite DI were worth $273,000 at the end of the most recent reporting period.
根据Yarbough Capital LLC最近提交给美国证券交易委员会(SEC)的文件,该公司在第二季度将其在Cellebrite DI Ltd.(纳斯达克代码:CLBT-GET评级)的头寸减少了17.2%。该公司在本季度出售了11,144股后,持有53,492股该公司股票。在最近一次报告期结束时,Yarbough Capital LLC持有的Cellebrite DI价值27.3万美元。
Several other hedge funds and other institutional investors have also recently modified their holdings of the company. CIBC Asset Management Inc raised its stake in shares of Cellebrite DI by 5.8% in the 1st quarter. CIBC Asset Management Inc now owns 2,352,733 shares of the company's stock valued at $15,057,000 after purchasing an additional 129,244 shares during the period. Phoenix Holdings Ltd. raised its stake in shares of Cellebrite DI by 303.6% in the 1st quarter. Phoenix Holdings Ltd. now owns 2,296,345 shares of the company's stock valued at $14,706,000 after purchasing an additional 1,727,379 shares during the period. Greenhaven Road Investment Management L.P. grew its holdings in shares of Cellebrite DI by 69.7% in the 1st quarter. Greenhaven Road Investment Management L.P. now owns 2,000,000 shares of the company's stock valued at $12,800,000 after acquiring an additional 821,364 shares in the last quarter. Blair William & Co. IL grew its holdings in shares of Cellebrite DI by 3,021.1% in the 1st quarter. Blair William & Co. IL now owns 523,978 shares of the company's stock valued at $3,353,000 after acquiring an additional 507,190 shares in the last quarter. Finally, ARK Investment Management LLC bought a new position in shares of Cellebrite DI in the 1st quarter valued at about $2,621,000. Institutional investors and hedge funds own 20.41% of the company's stock.
其他几家对冲基金和其他机构投资者最近也调整了对该公司的持股。加拿大帝国商业银行资产管理公司在第一季度将其在Cellebrite DI的股份增加了5.8%。加拿大帝国商业银行资产管理公司在此期间额外购买了129,244股后,现在拥有2,352,733股该公司股票,价值15,057,000美元。凤凰控股有限公司在第一季度增持了Cellebrite DI的股份303.6%。凤凰卫视控股有限公司目前持有该公司2,296,345股股票,价值14,706,000美元,在此期间又购买了1,727,379股。Greenaven Road Investment Management L.P.在第一季度持有的Cellebrite DI股票增加了69.7%。Greenaven Road Investment Management L.P.在上个季度增持了821,364股后,现在拥有200万股该公司股票,价值12,800,000美元。Blair William&Co.IL在第一季度增持了3,021.1%的Cellebrite DI股票。在上个季度增持了507,190股之后,Blair William&Co.IL现在持有523,978股该公司股票,价值3,353,000美元。最后,方舟投资管理有限责任公司在第一季度购买了Cellebrite DI的新头寸,价值约2,621,000美元。机构投资者和对冲基金持有该公司20.41%的股票。
Cellebrite DI Trading Down 2.0 %
Cellebrite DI降价2.0%
Shares of NASDAQ:CLBT traded down $0.09 during trading on Friday, reaching $4.37. 61,893 shares of the stock were exchanged, compared to its average volume of 144,907. Cellebrite DI Ltd. has a 12 month low of $4.10 and a 12 month high of $12.49. The stock has a 50-day moving average price of $5.12 and a 200-day moving average price of $5.43. The firm has a market cap of $823.92 million, a PE ratio of 5.91, a PEG ratio of 10.56 and a beta of 0.87.
纳斯达克:中国电信股价周五下跌0.09美元,至4.37美元。该股成交量为61,893股,而平均成交量为144,907股。Cellebrite DI Ltd.的股价跌至4.10美元的12个月低点和12.49美元的12个月高点。该股的50日移动均线价格为5.12美元,200日移动均线价格为5.43美元。该公司市值为8.2392亿美元,市盈率为5.91倍,市盈率为10.56倍,贝塔系数为0.87倍。
Wall Street Analyst Weigh In
华尔街分析师也加入进来
Cellebrite DI Company Profile
Cellebrite DI公司简介
(Get Rating)
(获取评级)
Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation.
Cellebrite DI Ltd.为法律批准的调查开发解决方案。其DI平台允许用户在整个调查生命周期中收集、审查、分析和管理与法律批准的调查有关的数字数据,并在各种案件中使用解决方案,包括剥削儿童、凶杀、反恐、边境控制、性犯罪、人口贩运、企业安全、知识产权盗窃和民事诉讼。
Featured Articles
专题文章
- Get a free copy of the StockNews.com research report on Cellebrite DI (CLBT)
- Stock Market: 3 Islands Of Strength In A Sea Of Red
- 3 Banks Worth Considering For Q4
- No One Told These 3 Stocks It's a Down Week
- MarketBeat: Week in Review 9/12 – 9/16
- Is There a Cure for What is Ailing Teladoc Stock?
- 免费获取StockNews.com关于Cellebrite DI(CLBT)的研究报告
- 股市:红海中的三座强国
- 第四季度值得考虑的3家银行
- 没有人告诉这三只股票这是下跌的一周
- MarketBeat:回顾一周9/12-9/16
- 有什么办法可以治愈Teladoc股票的问题吗?
Want to see what other hedge funds are holding CLBT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cellebrite DI Ltd. (NASDAQ:CLBT – Get Rating).
想看看还有哪些对冲基金持有CLBT吗?访问HoldingsChannel.com获取Cellebrite DI Ltd.(纳斯达克代码:CLBT-GET Rating)的最新13F备案文件和内幕交易信息。
Receive News & Ratings for Cellebrite DI Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cellebrite DI and related companies with MarketBeat.com's FREE daily email newsletter.
接受《凯尔布赖特DI日报》的新闻和评级-在下面输入您的电子邮件地址,通过MarketBeat.com的免费每日电子邮件时事通讯接收对Cellebrite DI和相关公司的最新新闻和分析师评级的每日简要摘要。